First Trust Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.5M | Buy |
|
|||||
|
2025
Q1 | $39.3M | Sell |
|
|||||
|
2024
Q4 | $49.5M | Buy |
|
|||||
|
2024
Q3 | $32.7M | Buy |
|
|||||
|
2024
Q2 | $33.6M | Buy |
|
|||||
|
2024
Q1 | $30.5M | Sell |
|
|||||
|
2023
Q4 | $55.6M | Buy |
|
|||||
|
2023
Q3 | $33.9M | Sell |
|
|||||
|
2023
Q2 | $60M | Sell |
|
|||||
|
2023
Q1 | $51.1M | Sell |
|
|||||
|
2022
Q4 | $45.9M | Sell |
|
|||||
|
2022
Q3 | $47.8M | Buy |
|
|||||
|
2022
Q2 | $30.6M | Sell |
|
|||||
|
2022
Q1 | $56.5M | Sell |
|
|||||
|
2021
Q4 | $78.3M | Buy |
|
|||||
|
2021
Q3 | $43.2M | Sell |
|
|||||
|
2021
Q2 | $71.3M | Buy |
|
|||||
|
2021
Q1 | $40.7M | Sell |
|
|||||
|
2020
Q4 | $86.7M | Sell |
|
|||||
|
2020
Q3 | $70.8M | Buy |
|
|||||
|
2020
Q2 | $68.8M | Sell |
|
|||||
|
2020
Q1 | $60.7M | Buy |
|
|||||
|
2019
Q4 | $61.1M | Sell |
|
|||||
|
2019
Q3 | $91.1M | Sell |
|
|||||
|
2019
Q2 | $113M | Sell |
|
|||||
|
2019
Q1 | $129M | Buy |
|
|||||
|
2018
Q4 | $66.9M | Sell |
|
|||||
|
2018
Q3 | $122M | Buy |
|
|||||
|
2018
Q2 | $39.8M | Buy |
|
|||||
|
2018
Q1 | $39.6M | Buy |
|
|||||
|
2017
Q4 | $45.9M | Buy |
|
|||||
|
2017
Q3 | $45.6M | Sell |
|
|||||
|
2017
Q2 | $39.1M | Buy |
|
|||||
|
2017
Q1 | $30M | Sell |
|
|||||
|
2016
Q4 | $30.9M | Buy |
|
|||||
|
2016
Q3 | $26.2M | Sell |
|
|||||
|
2016
Q2 | $27.8M | Buy |
|